Expression analysis of Akirin-2, NF κB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia.
DISCUSSION: We show for the first time that Akirin-2 can be a novel biomarker in imatinib resistance. Targeting Akirin-2, NFκB and β-catenin genes may provide an opportunity to overcome imatinib resistance in CML.
PMID: 29945498 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Genetics | Gleevec | Hematology | Leukemia | Myeloproliferative Disorders | Study